Drug firm Lupin today said it is reviewing an order by Federal Court of Australia awarding AUD 31.3 million to Bayer in a patent infringement lawsuit filed against two of the company's arms in the country.
Bayer Pharma Aktiengesellschaft and Bayer Australia Ltd had filed a patent infringement lawsuit against Generic Health Pty Ltd and Lupin Australia Pty Ltd, subsidiaries of the company, in the Federal Court of Australia, Lupin said in a filing to BSE.
The Bayer arms had alleged that sale of tablets by Lupin, containing Drospirenone 3 mg and Ethinyl Estradiol 30 microgram under the brand name 'Isabelle' infringed their Australian patent.
The judge issued an order awarding Bayer AUD 25.4 million in damages and AUD 5.9 million in pre-judgement interest. "We are in the process of reviewing the Judge's reasons for judgement and deciding next steps," Lupin said.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
